UBC® | IDL Biotech
IDL Biotech



UBC® is an immunoassay for both primary diagnosis and monitoring of bladder cancer. The test specifically measures soluble fragments of cytokeratin 8 and 18 in urine samples. . Elevated amounts of cytokeratin protein fragments are present in the urine of many individuals with bladder cancer, even at early stages of the disease.


UBC® is available in ELISA and Rapid format.

6 things you need to know about Bladder Cancer

New interesting findings for the tumor marker UBC® Rapid

Result from a new German multicenter study

Positive results for UBC Rapid in Clinical study

Evaluation of bladder cancer with point-of-care (POC) tests depends on the detection of bladder cancer associated proteins in urine samples.

UBC® Rapid is recommended to be added in the diagnostics of high grade bladder cancer tumours

Results from a published multicenter study

IDL Biotech

Skip this intro